Vitamin D insufficiency in CLL: a modifiable prognostic factor?
作者信息
Parikh Sameer A, Shanafelt Tait D
机构信息
Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.
Division of Hematology, Department of Medicine, Stanford University, Stanford, CA.
出版信息
Blood Adv. 2024 Jul 23;8(14):3838-3839. doi: 10.1182/bloodadvances.2024013428.
Abstract
摘要
相似文献
1
Vitamin D insufficiency in CLL: a modifiable prognostic factor?
Blood Adv. 2024 Jul 23;8(14):3838-3839. doi: 10.1182/bloodadvances.2024013428.
2
Serum 25-hydroxyvitamin D Insufficiency in B-Chronic Lymphoid Leukemia at the Time of Disease Presentation in Pakistan.
Asian Pac J Cancer Prev. 2015;16(14):5983-6. doi: 10.7314/apjcp.2015.16.14.5983.
3
Vitamin D insufficiency predicts time to first treatment (TFT) in early chronic lymphocytic leukemia (CLL).
Leuk Res. 2012 Apr;36(4):443-7. doi: 10.1016/j.leukres.2011.10.004. Epub 2011 Nov 1.
4
Vitamin D insufficiency and prognosis in chronic lymphocytic leukemia.
Blood. 2011 Feb 3;117(5):1492-8. doi: 10.1182/blood-2010-07-295683. Epub 2010 Nov 3.
5
Efficacy and safety of vitamin D supplementation in patients with chronic lymphocytic leukemia.
Postepy Hig Med Dosw (Online). 2016 May 21;70(0):534-41. doi: 10.5604/17322693.1202482.
6
Validation of a vitamin D replacement strategy in vitamin D-insufficient patients with lymphoma or chronic lymphocytic leukemia.
Blood Cancer J. 2017 Feb 3;7(2):e526. doi: 10.1038/bcj.2017.9.
7
Prognostic impact of serum 25-hydroxivitamin D [25(OH)D] concentrations in patients with lymphoid malignancies.
Hematology. 2013 Jan;18(1):20-5. doi: 10.1179/1607845412Y.0000000025. Epub 2012 Sep 12.
8
C-C motif ligand 11 reduction in CLL patients serum after vitamin D supplementation.
Hematology. 2016 Jul;21(6):343-50. doi: 10.1080/10245332.2016.1142162. Epub 2016 Mar 1.
9
Diabetes Mellitus Is Associated with Inferior Prognosis in Patients with Chronic Lymphocytic Leukemia: A Propensity Score-Matched Analysis.
Cancer Res Treat. 2020 Jan;52(1):189-206. doi: 10.4143/crt.2019.122. Epub 2019 Jul 1.
10
Use of positron emission tomography-computed tomography in the management of patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.
Leuk Lymphoma. 2014 Sep;55(9):2079-84. doi: 10.3109/10428194.2013.869801. Epub 2014 Feb 17.
本文引用的文献
1
Vitamin D supplement for patients with early-stage chronic lymphocytic leukemia is associated with a longer time to first treatment.
Blood Adv. 2024 Jul 23;8(14):3840-3846. doi: 10.1182/bloodadvances.2023011458.
2
Vitamin D and potential effects on cancers: a review.
Mol Biol Rep. 2024 Jan 25;51(1):190. doi: 10.1007/s11033-023-09111-y.
3
A Systematic Review Assessing the Impact of Vitamin D Levels on Adult Patients with Lymphoid Malignancies.
Curr Oncol. 2023 Apr 20;30(4):4351-4364. doi: 10.3390/curroncol30040331.
4
High-dose vitamin D supplementation in relapsing-remitting multiple sclerosis: a randomised clinical trial.
EClinicalMedicine. 2023 Apr 13;59:101957. doi: 10.1016/j.eclinm.2023.101957. eCollection 2023 May.
5
Vitamin D insufficiency predicts time to first treatment (TFT) in early chronic lymphocytic leukemia (CLL).
Leuk Res. 2012 Apr;36(4):443-7. doi: 10.1016/j.leukres.2011.10.004. Epub 2011 Nov 1.
6
Vitamin D insufficiency and prognosis in chronic lymphocytic leukemia.
Blood. 2011 Feb 3;117(5):1492-8. doi: 10.1182/blood-2010-07-295683. Epub 2010 Nov 3.
7
Vitamin D deficiency in adults: when to test and how to treat.
Mayo Clin Proc. 2010 Aug;85(8):752-7; quiz 757-8. doi: 10.4065/mcp.2010.0138.
8
Vitamin D deficiency.
N Engl J Med. 2007 Jul 19;357(3):266-81. doi: 10.1056/NEJMra070553.
9
The vitamin D3 analog EB1089 induces apoptosis via a p53-independent mechanism involving p38 MAP kinase activation and suppression of ERK activity in B-cell chronic lymphocytic leukemia cells in vitro.
Blood. 2003 Apr 1;101(7):2454-60. doi: 10.1182/blood-2002-07-1984. Epub 2002 Nov 21.
10
Photosynthesis of previtamin D3 in human skin and the physiologic consequences.
Science. 1980 Oct 10;210(4466):203-5. doi: 10.1126/science.6251551.
Zotero 插件